Charles River Laboratories International, Inc.
NYSE:CRL
Sector
Location
Market Cap
USD 7.80 B
Share Price
USD 158.48
Avg Daily Volume
890,756
Change (1 day)
0.96%
Change (1 year)
-22.32%
Change (YTD)
-14.15%
Charles River Laboratories International, Inc. Balance Sheet 2014 - 2024
This table shows the Balance Sheet for Charles River Laboratories International, Inc. going from 2014 until 2024. The balance sheet is a financial statement that presents the financial position of a company at a specific point in time, typically at the end of a fiscal period. It consists of three main components: assets (such as cash, inventory, property, and investments), liabilities (including debts, loans, and obligations), and shareholders' equity (the residual interest in the company's assets after deducting liabilities). The balance sheet provides insights into a company's liquidity, solvency, and overall financial health.
Balance Sheet
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Eli Lilly and Company
USD 703.21
LLY
+5.16
0.74%
AbbVie Inc.
USD 206.19
ABBV
-0.38
-0.18%
Roche Holding AG
USD 337.32
RO.SW
+4.54
1.36%
Novo Nordisk A/S
USD 54.16
NOVO-B.CO
-0.02
-0.03%
Novartis AG
USD 124.85
NOVN.SW
+0.78
0.63%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 84.93
MRK
+0.71
0.84%
Thermo Fisher Scientific Inc.
USD 498.29
TMO
+10.75
2.21%
Amgen Inc.
USD 295.55
AMGN
+2.93
1.00%
Gilead Sciences, Inc.
USD 117.98
GILD
-0.01
-0.01%
Pfizer Inc.
USD 25.32
PFE
+0.25
1.00%
Sanofi
USD 100.73
SAN.PA
+0.93
0.94%
Vertex Pharmaceuticals Incorporated
USD 390.76
VRTX
+0.88
0.23%
Bristol-Myers Squibb Company
USD 48.34
BMY
+0.15
0.31%
Chugai Pharmaceutical Co., Ltd.
USD 43.52
4519.T
-0.76
-1.72%